Agoura Health Products LLC
General
Total Cases1
Active Cases--
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
---|---|---|
01/24/25 | ORDER OF DISMISSAL [83] by Judge John W. Holcomb. Pursuant to the stipulation of the parties and in accordance with Rule 4l(a)(2) of the Federal Rules of Civil Procedure, it is hereby ORDERED that this entire action (including all claims, causes of action and counterclaims) is DISMISSED with prejudice, with each party to bear its own respective attorney's fees costs and expenses. IT IS SO ORDERED. (yl) (Entered: 01/24/2025) | |
01/24/25 | STIPULATION to Dismiss Case pursuant to Settlement filed by Plaintiffs Epitracker Inc., Seraphina Therapeutics Inc. (Attachments: # [1] Proposed Order)(Neubauer, Mark) (Entered: 01/24/2025) | |
12/27/24 | SCHEDULING NOTICE AND ORDER by Judge John W. Holcomb: In light of the Notice of Settlement filed December 27, 2024 [ECF No. 81], indicating that the case has settled, this action is placed in inactive status. By January 27, 2025, the parties shall file either (1) a Stipulation of Dismissal under Fed. R. Civ. P. 41(a)(1)(A)(i); (2) a Stipulation for an Order of Dismissal under Fed. R. Civ. P. 41(a)(2); or (3) a motion to reopen if settlement has not been consummated. Upon the failure to comply with this Order in a timely manner, this action shall be deemed dismissed as of January 28, 2025. This Court retains full jurisdiction over this action and this Order shall not prejudice any party. All previously set deadlines and dates are hereby VACATED. (JS-6) THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY (Entered: 12/27/2024) | |
12/27/24 | JOINT REPORT of Notice of Settlement in Principle filed by Defendants Agoura Health Products LLC, Steven R. Gundry. (Brosas, Josephine) (Entered: 12/27/2024) | |
11/18/24 | HEARING REGARDING SCHEDULING CONFERENCE held before Judge John W. Holcomb.. Court Reporter: Deborah Parker. The stay in this case is VACATED. The parties are DIRECTED to file no later than January 3, 2024, a Joint Status Report that advises the Court regarding the posture of the case. A continued Scheduling Conference is SET for January 10, 2025, at 11:00 a.m. If the parties wish to participate in a settlement conference before the Magistrate Judge, they may contact the Courtroom Deputy Clerk by email at JWH_Chambers@cacd.uscourts.gov. IT IS SO ORDERED. (yl) (Entered: 11/18/2024) | |
10/28/24 | SCHEDULING NOTICE AND ORDER by Judge John W. Holcomb: On its own motion, the Court SETS a Scheduling Conference on Friday, November 15, 2024, at 11:00 a.m. Counsel for the parties are DIRECTED to appear in person in Courtroom 9D, on the 9th Floor of the Ronald Reagan Federal Building and United States Courthouse at 411 W. Fourth Street Santa Ana, CA 92701. IT IS SO ORDERED. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY (Entered: 10/28/2024) | |
10/25/24 | STATUS REPORT - JOINT STATUS REPORT filed by Plaintiffs Epitracker Inc., Seraphina Therapeutics Inc. (Attachments: # [1] Exhibit 1)(Neubauer, Mark) (Entered: 10/25/2024) | |
10/22/24 | Notice of Appearance or Withdrawal of Counsel: for attorney Mark A. Neubauer counsel for Plaintiffs Epitracker Inc., Seraphina Therapeutics Inc. Lauren M. Doxey is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Plaintiffs Epitracker, Inc. and Seraphina Therapeutics, Inc.. (Neubauer, Mark) (Entered: 10/22/2024) | |
09/06/24 | STATUS REPORT - JOINT filed by Plaintiffs Epitracker Inc., Seraphina Therapeutics Inc. (Attachments: # [1] Exhibit A)(Neubauer, Mark) (Entered: 09/06/2024) | |
06/17/24 | ORDER STAYING LITIGATION [74] by Judge John W. Holcomb. This action is STAYED, all hearing dates VACATED, and all deadlines SUSPENDED, pending a final decision from the United States Patent and Trademark Office ("USPTO") (not including any appeals to the Patent Trial and Appeal Board) in the reexamination of U.S. Patent No. 11,116,740, Reexamination Control No. 90/019,345. The parties are DIRECTED to file a Joint Status Report no later than September 13, 2024, and every 90 days thereafter, advising the Court of the posture of the Reexamination.The parties are also DIRECTED to confer and to provide the Court with a Joint Status Report within 14 days of the USPTO's final decision in the Reexamination. IT IS SO ORDERED. (See document for further details) (yl) (Entered: 06/17/2024) |